TABLE 2.
Patient ID# |
Gender | Age (years) |
CD4 (cells/ mL) |
Hbe Ag |
HDV Ab |
HBV DNA plasma log10 IU/mL |
HBV DNA CSF log10 IU/mL |
HIV RNA plasma log10 c/mL |
HIV RNA CSF log10 c/mL |
Albumin index (N < 9) |
CSF albumin levels (g/L) |
CSF pleocytosis (WBC/mL of CSF) |
Previous cART |
Length of current exposure to 3TC (months) |
Neurological diagnosis |
MRI demyelinating lesions |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 21 | 7 | N/A | N/A | 9.46 | 4.7 | 4.61 | 4.3 | 10.81 | 0.4 | 4 | no | — | HIVE | yes |
2 | F | 16 | 125 | pos | N/A | 8.84 | 3.36 | 6.01 | 2.48 | N/A | N/A | N/A | yes | — | stroke | yes |
3 | M | 18 | 37 | N/A | N/A | 8.72 | 4.69 | 2.79 | 2.6 | 18.86 | 0.66 | 46 | yes | 5 | stroke | yes |
4 | M | 17 | 490 | pos | N/A | 8.24 | 5.58 | 5.11 | 5.85 | 27.73 | 0.99 | 5 | yes | — | HIVE | yes |
5 | M | 17 | 220 | N/A | N/A | 7.65 | 5.36 | 4.18 | 3.44 | 17.55 | 0.66 | N/A | no | — | viral encephalitis | no |
6 | F | 15 | 8 | N/A | N/A | 7.54 | 3.42 | 4.58 | 2.72 | 2.62 | 0.1 | 3 | no | — | viral encephalitis | yes |
7 | F | 20 | 59 | pos | neg | 6.87 | 4.12 | 5.92 | 5.78 | 8.88 | 0.3 | 10 | yes | 2 | CMV encephalitis | yes |
8 | M | 14 | 13 | pos | neg | 6.34 | 3.3 | 5.34 | 4.36 | 12.35 | 0.4 | 5 | No | — | Tx | — |
9 | M | 17 | 1 | pos | neg | 5.77 | 4.91 | 5.61 | 2.89 | 73.33 | 1.98 | 20 | yes | — | SME | yes |
10 | M | 15 | 182 | pos | neg | 5.73 | 2.98 | 5.15 | 2.59 | 15.31 | 0.66 | 1 | yes | — | facial paresis | normal |
11 | F | 20 | 348 | pos | N/A | 5.73 | 1.78 | 4.11 | 3.32 | 6.01 | 0.2 | 3 | no | — | HIVE | — |
12 | M | 16 | 380 | pos | N/A | 5.07 | 1.78 | 2.25 | 2.25 | 2.06 | 0.1 | 3 | yes | 60 | stroke | — |
13 | M | 14 | 19 | pos | neg | 4.85 | 1.78 | 5.82 | 3.69 | 2.78 | 0.1 | 1 | yes | 49 | PML | yes |
14 | F | 20 | 231 | neg | N/A | 4.6 | 2.26 | 3.6 | 2.6 | 2.49 | 0.1 | 4 | yes | 13 | SME | yes |
15 | M | 15 | 7 | pos | N/A | 3.38 | 1.78 | 2.6 | 2.6 | 16.92 | 0.66 | 3 | yes | 1 | PML | yes |
16 | M | 16 | 306 | pos | pos | 3.24 | 1.78 | 2.6 | 2.6 | 2.65 | 0.1 | 2 | yes | 9 | behaviour changes | no |
17 | M | 17 | 16 | neg | pos | 3.15 | 1.78 | 4.8 | 2.6 | 2.53 | 0.1 | 1 | yes | 29 | SME | yes |
18 | F | 18 | 325 | neg | neg | 3.03 | 1.78 | 3.79 | 2.25 | 18.33 | 0.66 | 6 | yes | 36 | epilepsy | normal |
19 | F | 16 | 8 | pos | pos | 1.78 | 1.78 | 3.2 | 2.6 | 2.90 | 0.1 | 3 | yes | 45 | evaluation Hodgkin lymphoma |
normal |
20 | F | 16 | 305 | neg | N/A | 1.78 | 1.78 | 3.62 | 4 | 33.08 | 1.32 | 22 | yes | viral encephalitis | — | |
21 | M | 16 | 1 | neg | pos | 1.78 | 1.78 | 2.25 | 2.43 | 3.65 | 0.1 | 3 | yes | 42 | SME | yes |
22 | F | 18 | 220 | neg | neg | 1.78 | 1.78 | 1.7 | 1.7 | 2.54 | 0.1 | 12 | yes | 22 | HIVE | no |
23 | M | 18 | 738 | N/A | N/A | 1.78 | 1.78 | 1.7 | 1.7 | 2.45 | 0.1 | 2 | yes | 69 | HIVE | — |
24 | F | 20 | 406 | neg | neg | 1.78 | 1.78 | 1.67 | 1.67 | 2.34 | 0.1 | 2 | yes | 24 | HIVE | — |
25 | F | 19 | 255 | neg | neg | 1.78 | 1.78 | 2.72 | 1.7 | 2.38 | 0.1 | 4 | yes | 9 | HIVE | — |
26 | M | 21 | 146 | neg | neg | 1.78 | 1.78 | 4.8 | 5.1 | 6.90 | 0.2 | 22 | no | — | HIVE | yes |
Abbreviations: HBe Ag, hepatitis B e antigen; HDV Ab, hepatitis D virus antibodies; HBV, hepatitis B virus; CSF, cerebrospinal fluid; WBC, white blood cells; cART, combination antiretroviral therapy; HIVE, HIV encephalopathy; SME, measles inclusion body encephalitis or subacute myoclonic measles encephalitis; PML, progressive multifocal leucoencephalopathy; Tx, cerebral toxoplasmosis.